Medicilon
GSK
University of Science and Technology of China
Harvard University
Alex ZhavoronkovFounder, Chair and CEO · Insilico MedicineFounder↗
Researcher · Executive
Feng Ren
Insilico MedicineChief Scientific Officer, Executive Director & Co-CEO
Ren leads Insilico Medicine's drug research, turning molecules proposed by generative AI into laboratory and clinical programs. A medicinal chemist who previously led neuroscience discovery at GSK, he provides the experimental and development expertise needed to test whether AI-designed drugs work in the real world.
Career & education
Current roleInsilico Medicine2021-presentChief Scientific Officer, Executive Director & Co-CEO
Insilico Medicine2021-presentPreviously
Work and education history is primarily focused on AI-relevant roles and may not be comprehensive.
Citation Trend
Total citations to scholarly work, including research papers, technical reports, books and theses, as recorded by Google Scholar. Each point is a dated snapshot.
citations4,248As of Oct 23, '26
citations+643Since last snapshot, Jul 2, '26
Updates 1
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.
Reviewed August 8, 2026 · Checked for accuracy and new information.